What is ADMA Biologics's EV / EBITDA?

ADMA Biologics (ADMA) reported EV / EBITDA of 9.9× in Q1 2026.

How has ADMA Biologics's EV / EBITDA changed year-over-year?

ADMA Biologics's EV / EBITDA decreased by 65.9% year-over-year, from 29.1× to 9.9×.

What is the long-term trend for ADMA Biologics's EV / EBITDA?

Over 2 years (2023 to 2025), ADMA Biologics's EV / EBITDA has grown at a -19.5% compound annual growth rate (CAGR), from 33.6× to 21.7×.

What does EV / EBITDA mean?

Enterprise value (market cap plus total debt minus cash) at the quarter end divided by trailing-twelve-month EBITDA. A capital-structure-neutral valuation multiple.

ADMA Biologics ADMA EV / EBITDA

EV / EBITDA at other companies

AnaptysBio, Inc.ANAB

32.6×—

ZymeworksZYME

2.2×—

Quest DiagnosticsDGX

12.6×-0.6×

AbbVieABBV

19.8×—

AmgenAMGN

15.9×-1.3×

TG TherapeuticsTGTX

37.5×-67.9×

Other financials

Income statement

See full

Revenue$114.5M-0.3%

Gross profit$80.8M+32.2%

Operating income$58.3M+67.1%

Net income$45.3M+68.5%

EPS (diluted)$0.19+72.7%

Balance sheet

See full

Cash & equivalents$138.2M+92.9%

Total debt$204.4M+2,055%

Total equity$390.3M+4.5%

Total assets$665.2M+30.3%

Cash flow

See full

Operating cash flow$58.2M+396%

CapEx$2.5M-45.9%

Free cash flow$55.7M+329%

Valuation

See full

Market cap$2.01B-54.5%

Enterprise value$2.08B-52.5%

P/E12.2×-9.2×

P/S4×-5.7×

Profitability

See full

Gross margin61.3%+8.7pp

Operating margin42.1%+9.0pp

Net margin32.4%-12.6pp

FCF margin21.2%+1.4pp

Returns & leverage

See full

Return on equity43.3%-35.2pp

Debt / equity0.5×+0.5×

Current ratio7×+0.4×

Where this comes from

Calculated from ADMA Biologics’s reported figures.

enterprise value/ebitda=9.9×

Based on the most recent quarter.

The official record: ADMA Biologics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about ADMA Biologics's ev / ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is ADMA Biologics's EV / EBITDA?: ADMA Biologics (ADMA) reported EV / EBITDA of 9.9× in Q1 2026.
How has ADMA Biologics's EV / EBITDA changed year-over-year?: ADMA Biologics's EV / EBITDA decreased by 65.9% year-over-year, from 29.1× to 9.9×.
What is the long-term trend for ADMA Biologics's EV / EBITDA?: Over 2 years (2023 to 2025), ADMA Biologics's EV / EBITDA has grown at a -19.5% compound annual growth rate (CAGR), from 33.6× to 21.7×.
What does EV / EBITDA mean?: Enterprise value (market cap plus total debt minus cash) at the quarter end divided by trailing-twelve-month EBITDA. A capital-structure-neutral valuation multiple.